Integrative analysis of metabolome and gut microbiota in diet-induced hyperlipidemic rats treated with berberine compounds

BACKGROUND: Hyperlipidemia is a major component of metabolic syndrome, and often predicts cardiovascular diseases. We developed a new therapeutic agent berberine compounds (BC), consisting of berberine, oryzanol and vitamin B(6), and determined their anti-hyperlipidemia activity and underlying mecha...

Full beskrivning

Bibliografiska uppgifter
Huvudupphovsmän: Li, Meng, Shu, Xiangbing, Xu, Hanchen, Zhang, Chunlei, Yang, Lili, Zhang, Li, Ji, Guang
Materialtyp: Online Artikel Text
Språk:English
Publicerad: BioMed Central 2016
Ämnen:
Research
Länkar:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4975912/
https://www.ncbi.nlm.nih.gov/pubmed/27495782
http://dx.doi.org/10.1186/s12967-016-0987-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4975912/
https://www.ncbi.nlm.nih.gov/pubmed/27495782
http://dx.doi.org/10.1186/s12967-016-0987-5

Liknande verk